Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Malaria parasite’s sweet tooth found

04.06.2003


A completely new way of killing the malaria parasite has been found by researchers at St George’s Hospital Medical School in London. Professor Sanjeev Krishna’s research group is world-renowned in the battle against infectious diseases and has now discovered how to stop the malaria parasite’s sugar transport protein from working. This prevents the parasite growing and multiplying in the red blood cells where it lives. The research is published this week in the Proceedings of the National Academy of Sciences and was predominately funded by the Medical Research Council.



Malaria kills 3,000 children every day and the parasite that causes malaria is becoming harder to treat as it becomes resistant to more and more drugs. New ways of fighting this dangerous infection are needed urgently.

Now researchers at St George’s Hospital Medical School, in collaboration with colleagues at Université Joseph Fourier, Grenoble, France, and the London School of Tropical Medicine, have discovered a chink in the malaria parasite’s armour – its sweet tooth. The malaria parasite needs sugar in the form of glucose to grow and multiply in the red blood cells. It uses what is known as a parasite-encoded facilitative hexose transporter (PfHT) (a special transport protein) to absorb the glucose around it. By introducing a new compound, the scientists stop the parasite’s sugar transport protein from working. Blocking this glucose uptake kills even drug resistant strains of the parasite.


“We have spent ten years developing new ways of studying parasite transport proteins so that we could work out how to block the action of the glucose transporter. This discovery proves for the first time that it is worth going after transport proteins of the malaria parasite and that parasites cannot live without this transporter working properly,” says Professor Krishna. “We are very excited about this research, as this new information gives us the potential to design new drugs against malaria.”

Alice Bows | alfa
Further information:
http://www.sghms.ac.uk

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>